Current Neurovascular Research published that very specific stem cell injection and infusion treatment protocols were administered to multiple patients, and after 2 years’ follow-up, EDSS scores improved in 80%, while relapse occurrence significantly decreased in 100%. MRI revealed lesions significantly decreased six months after the treatments.

*Human Umbilical Cord Mesenchymal Stem Cell Therapy On Neuromyolitis Optica. Current Neurovascular Research 2012;9:250-5.